We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ikena Oncology Inc | NASDAQ:IKNA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.02 | -1.13% | 1.75 | 1.55 | 1.84 | 1.76 | 1.72 | 1.74 | 147,449 | 05:00:10 |
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trade
Symbol(s)
|
Name of each exchange
on which registered
|
||
|
|
|
Item 5.07 |
Submission of Matters to a Vote of Security Holders.
|
For
|
Against
|
Abstain
|
|||
25,681,604
|
12,086
|
1,156
|
For
|
Against
|
Abstain
|
|||
26,947,409
|
394,239
|
729
|
Ikena Oncology, Inc.
|
||
Date: October 11, 2023
|
By:
|
/s/ Mark Manfredi
|
Mark Manfredi, Ph.D.
|
||
President and Chief Executive Officer
|
Document and Entity Information |
Oct. 11, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Oct. 11, 2023 |
Entity File Number | 001-40287 |
Entity Registrant Name | IKENA ONCOLOGY, INC. |
Entity Central Index Key | 0001835579 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 81-1697316 |
Entity Address, Address Line One | 645 Summer Street |
Entity Address, Address Line Two | Suite 101 |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02210 |
City Area Code | 857 |
Local Phone Number | 273-8343 |
Title of 12(b) Security | Common Stock, $0.001 par value per share |
Trading Symbol | IKNA |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
1 Year Ikena Oncology Chart |
1 Month Ikena Oncology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions